Paeds Cases · adolescent-and-young-adult-medicine
Adolescent STI encounter OSCE — confidentiality, site-based testing and safety
Observed structured encounter testing private time, conditional confidentiality, the 5 P's history, risk- and anatomy-based testing, pregnancy-aware treatment and a PID red-flag assessment.
On this page & tools
Target exams
Station objectives
- Negotiate private time and explain conditional confidentiality. [5]
- Take a 5 P's sexual history with inclusive, non-judgemental language. [2]
- Choose test sites by disclosed anatomy and exposure. [3]
- Apply pregnancy-aware treatment and partner services. [2] [6]
- Assess PID severity and disposition. [4]
Candidate brief
You are the paediatric doctor in adolescent clinic. You have 10 minutes for Station A (confidential screening with a reluctant parent) and 12 minutes for Station B (return visit with pelvic pain). Examiners score process, safety and partnership language. [5] [2]
Station A — Parent resists leaving
Setup: A 16-year-old and her mother attend for a check-up. The mother says "we have no secrets in this family." [5]
Expected actions:
- Greet the young person first; set a joint agenda. [5]
- Explain that private time is standard adolescent care, not suspicion. [5]
- State conditional confidentiality with clear limits (harm, abuse, legal duties). [5]
- Take a 5 P's history in private, including a coercion question. [2]
- Offer universal chlamydia/gonorrhoea screening plus HIV and syphilis by risk; offer self-collection. [1]
- Sample by disclosed practices — add pharyngeal/rectal NAAT when oral or anal exposure is reported. [3]
Station B — Pelvic pain, fever and cervical motion tenderness
Setup: Two weeks later the young person returns with bilateral lower abdominal pain, fever and tenderness on bimanual examination; a recent chlamydia NAAT was positive and only partially treated. [4]
Expected actions:
- Recognise pelvic inflammatory disease and assess for features in serious illness (FIRH): fever, rigors, peritoneal signs, vomiting, haemodynamics. [4]
- Send a urine pregnancy test before deciding treatment (doxycycline contraindicated in pregnancy). [2]
- Apply inpatient criteria: systemic toxicity, pregnancy, intolerance, non-adherence risk or diagnostic uncertainty. [4]
- Arrange parenteral therapy, analgesia and gynaecology liaison; exclude ectopic pregnancy and appendicitis. [4]
- Plan partner treatment and rescreening at about three months. [6]
Marking anchors
Clear pass: secures private time, correct confidentiality limits, structured 5 P's history, site-based testing, pregnancy test before treatment, correct PID severity assessment and disposition, non-judgemental and safeguarding-aware language. [5] [2] [4] Borderline: good rapport but incomplete site testing, omitted pregnancy test, or vague follow-up and partner plan. [3] [6] Fail: no private time; absolute secrecy promise; urine-only testing despite disclosed anal exposure; oral outpatient therapy for severe PID with toxicity; judgemental language. [5] [4]
Debrief pearls
- Screening waits for no symptoms: universal CT/GC for sexually active females under 25. [1]
- Test by exposure, not gender; add extragenital sites when relevant. [3]
- Pregnancy-test before any tetracycline; severe PID needs inpatient parenteral care. [2] [4]
- Treat partners and rescreen at about three months; layer condoms, HPV vaccine and PrEP. [6] [8]
References
- [1]US Preventive Services Task Force; Davidson KW; Barry MJ Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement. JAMA, 2021.PMID 34519796
- [2]Workowski KA; Bachmann LH; Chan PA Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep, 2021.PMID 34292926
- [3]Bamberger DM; Graham G; Dennis L Extragenital Gonorrhea and Chlamydia Among Men and Women According to Type of Sexual Exposure. Sex Transm Dis, 2019.PMID 30676485
- [4]Gray-Swain MR; Peipert JF Pelvic inflammatory disease in adolescents. Curr Opin Obstet Gynecol, 2006.PMID 16932044
- [5]Friedman JC; Cannon B; Tyson N Providing adolescent-friendly sexually transmitted infection screening and treatment services. Curr Opin Obstet Gynecol, 2024.PMID 39109588
- [6]Jamison CD; Coleman JS; Mmeje O Improving Women's Health and Combatting Sexually Transmitted Infections Through Expedited Partner Therapy. Obstet Gynecol, 2019.PMID 30741802
- [7]US Preventive Services Task Force; Mangione CM; Barry MJ Screening for Syphilis Infection in Nonpregnant Adolescents and Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA, 2022.PMID 36166020
- [8]US Preventive Services Task Force; Barry MJ; Nicholson WK Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement. JAMA, 2023.PMID 37606666